ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 387 filers reported holding ENCOMPASS HEALTH CORP in Q2 2018. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $1,916 | -2.7% | 28,715 | -2.0% | 0.01% | -28.6% |
| Q3 2023 | $1,969 | -8.0% | 29,315 | -7.3% | 0.01% | 0.0% |
| Q2 2023 | $2,141 | +23.3% | 31,615 | -1.5% | 0.01% | +16.7% |
| Q1 2023 | $1,737 | -32.2% | 32,104 | -25.1% | 0.01% | -33.3% |
| Q4 2022 | $2,562 | -99.9% | 42,839 | +0.0% | 0.01% | +28.6% |
| Q3 2022 | $1,937,000 | +3.8% | 42,819 | +2.3% | 0.01% | 0.0% |
| Q2 2022 | $1,866,000 | -39.9% | 41,861 | -4.2% | 0.01% | -30.0% |
| Q1 2022 | $3,106,000 | +1001.4% | 43,677 | +972.6% | 0.01% | +900.0% |
| Q4 2019 | $282,000 | -23.2% | 4,072 | -29.9% | 0.00% | -50.0% |
| Q3 2019 | $367,000 | +29.7% | 5,805 | +29.8% | 0.00% | +100.0% |
| Q2 2019 | $283,000 | -18.0% | 4,473 | -24.2% | 0.00% | -50.0% |
| Q1 2019 | $345,000 | -57.2% | 5,899 | -54.9% | 0.00% | -50.0% |
| Q4 2018 | $806,000 | -56.4% | 13,069 | -44.9% | 0.00% | -50.0% |
| Q3 2018 | $1,849,000 | +28.4% | 23,722 | +11.6% | 0.01% | +33.3% |
| Q2 2018 | $1,440,000 | – | 21,263 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DARUMA CAPITAL MANAGEMENT LLC | 587,603 | $45,804,000 | 4.32% |
| Kalos Management, Inc. | 77,043 | $6,000,000 | 3.22% |
| MARIETTA INVESTMENT PARTNERS LLC | 101,122 | $7,882,000 | 2.34% |
| Copeland Capital Management, LLC | 471,462 | $36,750,000 | 2.22% |
| REINHART PARTNERS, LLC. | 278,916 | $21,742,000 | 1.97% |
| Rock Springs Capital Management LP | 676,500 | $52,733,000 | 1.91% |
| Wolf Group Capital Advisors | 35,599 | $2,775,000 | 1.81% |
| GARRISON BRADFORD & ASSOCIATES INC | 27,608 | $2,152,000 | 1.73% |
| BROADVIEW ADVISORS LLC | 123,907 | $9,659,000 | 1.65% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 70,000 | $5,457,000 | 1.64% |